Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

7530416G11Rik Inhibitors

The class of "7530416G11Rik Inhibitors" encompasses a diverse range of chemical compounds, each with unique biochemical properties and specific mechanisms of action. Although these compounds are not directly associated with 7530416G11Rik due to the limited scientific data available, they are known to modulate various cellular signaling pathways that could indirectly influence the activity of proteins encoded by this gene.

Temsirolimus and Everolimus, both mTOR inhibitors, play a critical role in regulating cell growth, proliferation, and survival. By modulating the mTOR pathway, they could potentially influence the activity of proteins similar to those encoded by 7530416G11Rik. Bortezomib, a proteasome inhibitor, affects protein degradation and cell cycle regulation, potentially impacting proteins involved in these processes.

Zoledronic Acid, a bisphosphonate, is known for its effect on bone metabolism and calcium signaling, which could indirectly influence proteins involved in these pathways. Celecoxib, a COX-2 inhibitor, modulates inflammatory pathways and could affect cell proliferation, potentially impacting proteins involved in these processes.

Lapatinib, Vandetanib, and Erlotinib are tyrosine kinase inhibitors targeting EGFR, HER2, VEGFR, and RET. These kinases are crucial in cell growth, survival, and angiogenesis. By inhibiting these kinases, these compounds might indirectly influence the activity or expression of proteins encoded by genes like 7530416G11Rik.

Sorafenib and Sunitinib, as multi-kinase inhibitors, exhibit diverse effects on cell proliferation, angiogenesis, and apoptosis pathways. Pazopanib's inhibition of VEGFR, PDGFR, and KIT also impacts angiogenesis and cell growth. Axitinib specifically inhibits VEGFR, further influencing angiogenesis and tumor growth.

In summary, the "7530416G11Rik Inhibitors" class represents a comprehensive approach to understanding and modulating cellular signaling pathways. These compounds serve as valuable tools for research into the functional aspects of proteins and their role in various cellular processes. While direct inhibitors of 7530416G11Rik are not specified due to the lack of detailed information on the protein, this class of inhibitors presents a broad method for exploring the modulation of protein activity within complex cellular networks. Their diverse mechanisms of action, from targeting receptor tyrosine kinases to influencing metabolic pathways, highlight the intricate balance of cellular processes and offer insights into the potential regulation of proteins encoded by genes like 7530416G11Rik.

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

A proteasome inhibitor, potentially affecting protein degradation and cell cycle regulation.

Everolimus

159351-69-6sc-218452
sc-218452A
5 mg
50 mg
$128.00
$638.00
7
(1)

Another mTOR inhibitor, potentially influencing cellular growth, proliferation, and survival.

Zoledronic acid, anhydrous

118072-93-8sc-364663
sc-364663A
25 mg
100 mg
$90.00
$251.00
5
(0)

A bisphosphonate, potentially affecting bone metabolism and calcium signaling pathways.

Lapatinib

231277-92-2sc-353658
100 mg
$412.00
32
(1)

Dual inhibitor of EGFR and HER2 tyrosine kinases, potentially influencing cell growth and survival pathways.

Vandetanib

443913-73-3sc-220364
sc-220364A
5 mg
50 mg
$167.00
$1353.00
(1)

Inhibits VEGFR, EGFR, and RET tyrosine kinases, potentially affecting angiogenesis and cell growth.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

Multi-kinase inhibitor, potentially affecting cell proliferation, angiogenesis, and apoptosis pathways.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$150.00
$920.00
5
(0)

Inhibits various tyrosine kinases, potentially impacting angiogenesis and tumor cell proliferation.

Pazopanib

444731-52-6sc-396318
sc-396318A
25 mg
50 mg
$127.00
$178.00
2
(1)

Inhibits VEGFR, PDGFR, and KIT tyrosine kinases, potentially affecting angiogenesis and cell growth pathways.

Erlotinib Hydrochloride

183319-69-9sc-202154
sc-202154A
10 mg
25 mg
$74.00
$119.00
33
(1)

EGFR tyrosine kinase inhibitor, potentially affecting cell proliferation and apoptosis pathways.